Back

A tonsil organoid model reveals Epstein-Barr virus infected germinal center B cell states during primary infection

Mitul, M. T.; Sun, Y.; Yates, T. B.; Sureshchandra, S.; Kastenschmidt, J. M.; Sorn, A. M.; Wagoner, Z. W.; Joloya, E. M.; Nair, A. K.; Daugherty, A.; Saligrama, N.; Ahuja, G.; Zhong, Q.; Trask, D.; Kottyan, L. C.; Weirauch, M. T.; Forney, C.; Gewurz, B. E.; Wagar, L. E.

2026-01-15 immunology
10.64898/2026.01.15.699764 bioRxiv
Show abstract

Epstein-Barr virus (EBV) colonizes secondary lymphoid tissues to establish persistent infection and is strongly associated with malignancy and autoimmunity. Our understanding of EBV infection biology is hindered by a lack of models that capture infected B cell activity in the lymphoid tissue microenvironment. We therefore developed an EBV human tonsil organoid model to evaluate key B cell states and antiviral responses, including after primary infection. EBV promoted B cell differentiation into germinal center (GC)-like phenotypes and transcriptomic analyses highlighted numerous B cell transcriptional programs unique to EBV-infected cells. B cell receptor repertoire analysis revealed that most EBV-infected B cells underwent class switching but only rarely participated in somatic hypermutation. CD4 T cells, highly activated by organoid infection, limited EBV+ B cell outgrowth. Our findings demonstrate human tonsil organoids as a physiologically relevant model to investigate key aspects of EBV immunity and pathogenesis.

Published in Proceedings of the National Academy of Sciences (predicted rank #8) · training set

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.